ABSTRACT
BACKGROUND
Little is known about factors associated with willingness to undergo colorectal cancer (CRC) screening for personal or public health benefit among women from diverse race/ethnic groups.
OBJECTIVE
To evaluate factors associated with willingness to undergo CRC screening for personal and public health benefit among women from diverse race/ethnic groups.
METHODS
We interviewed women aged 50 to 80 from four racial/ethnic groups from primary care clinics in 2003–2005. We asked about demographics, CRC screening knowledge and history, perceived risk of colon cancer, and about the outcomes of intention to be screened for personal benefit and for public health benefit.
RESULTS
Of the 492 women who completed the interview, 32 % were White, 16 % were African American, 21 % were Latina and 32 % were Asian. Up-to-date screening was reported by 77 % of women, with similar numbers obtaining fecal occult blood test (FOBT) within 2 years or colonoscopy within 10 years. The majority of women were “likely or very likely” to get FOBT or colonoscopy after learning the benefits and risks. Multivariate models showed that compared to Whites, fewer Asians would undergo colonoscopy (OR = 0.28; 95 % CI: 0.12, 0.63), while more Latinas would undergo colonoscopy (OR = 6.14; 95 % CI: 1.77, 21.34) and obtain regular CRC screening (OR = 4.47; 95 % CI: 1.66, 12.04). The majority would obtain CRC screening even if they would not personally benefit; those who perceived themselves to be at higher than average cancer risk were more likely to participate in CRC screening for public health benefit (OR = 2.32; 95 % CI: 1.32, 4.09).
CONCLUSIONS
The majority of women are willing to undergo screening for personal benefit. Asians were less likely, and Latinas more likely, to accept colonoscopy. Most are also willing to undergo screening for public health benefit. Self-perceived risk of CRC was the most consistent predictor of willingness and intention to be screened for either personal or public health benefit
Similar content being viewed by others
REFERENCES
Centers for Disease Control and Prevention, Cancer Screening - United States, 2010. MMWR. 2012;61(3):41–45.
Shokar NK, Carlson CA, Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med. 2008;21(5):414–26.
Walsh JM, Kaplan CP, Nguyen B, Gildengorin G, McPhee SJ, Pérez-Stable EJ. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med. 2004;19(2):156–66.
Weinberg DS, Turner BJ, Wang H, Myers RE, Miller S. A survey of women regarding factors affecting colorectal cancer screening compliance. Prev Med. 2004;38(6):669–75.
Kim SE, Pérez-Stable EJ, Wong S, et al. Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med. 2008;168(7):728–34.
Huang AJ, Pérez-Stable EJ, Kim SE, et al. Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med. 2008;23(9):1324–9.
Sawaya GF, Iwaoka-Scott AY, Kim S, et al. Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women. Am J Obstet Gynecol. 2009;200(1):40. e41–47.
Kaplan C, Kim S, Wong S, Walsh J, Pérez-Stable EJ. Willingness to Use Tamoxifen to Prevent Breast Cancer among Diverse Women. Breast Cancer Res Treat. 2012;133(1):357–66.
Wong ST, Pérez-Stable EJ, Kim SE, et al. Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns. 2012;87(3):327–35.
Denberg TD, Wong S, Beattie A. Women’s misconceptions about cancer screening: implications for informed decision-making. Patient Educ Couns. 2005;57(3):280–5.
Harris-Kojetin LD, Fowler FJ Jr, Brown JA, Schnaier JA, Sweeny SF. The use of cognitive testing to develop and evaluate CAHPS 1.0 core survey items. Consumer Assessment of Health Plans Study. Med Care. 1999;37(3):MS10-21.
Ware J, Kosinski M, Turner-Bowker D, Gandek B. How to score version 2 of the SF-12 Health Survey (With a Supplement Documenting Version 1). Lincoln, RI: QualityMetric Inc; 2002.
Lipkus IM. Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. Med Decis Making. 2007;27(5):696–713.
Lipkus IM, Hollands JG. The visual communication of risk. J Natl Cancer Inst Monogr. 1999;25:149–63.
Weinstein ND. What does it mean to understand a risk? Evaluating risk comprehension. J Natl Cancer Inst Monogr. 1999;25:15–20.
American Cancer Society. Cancer Prevention & Early Detection Facts and Figures. 2011; http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029459.pdf. (Accessed August, 2012).
Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638–58.
Stata Statistical Software [computer program]. Version 9. College Station, TX2005.
Dillard AJ, Ferrer RA, Ubel PA, Fagerlin A. Risk perception measures’ associations with behavior intentions, affect, and cognition following colon cancer screening messages. Health Psychol. 2012;31(1):106–13.
McCarthy BD, Moskowitz MA. Screening flexible sigmoidoscopy: patient attitudes and compliance. J Gen Intern Med. 1993;8(3):120–5.
Walsh JM, Salazar R, Nguyen TT, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1–14.
Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: A randomized trial of competing strategies. Arch Intern Med. 2012;172:575–82.
Cameron KA, Francis L, Wolf MS, Baker DW, Makoul G. Investigating Hispanic/Latino perceptions about colorectal cancer screening: a community-based approach to effective message design. Patient Educ Couns. 2007;68(2):145–52.
Myers RE, Trock BJ, Lerman C, Wolf T, Ross E, Engstrom PF. Adherence to colorectal cancer screening in an HMO population. Preventive medicine. 1990;19(5):502–14.
Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L. Adherence to continuous screening for colorectal neoplasia. Med Care. 1993;31(6):508–19.
Sutton S, Wardle J, Taylor T, et al. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen. 2000;7(2):99–104.
USPSTF. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.
Acknowledgements
This study was supported by the Agency for Healthcare Research and Quality (5P01 HS10856) for an Excellence Center to Eliminate Ethnic/Racial Disparities (EXCEED); by Grant P30-AG15272 under the Resource Centers for Minority Aging Research program by the National Institute on Aging, National Institutes of Health; by Redes En Acción: The National Latino Cancer Network Grant U01-CA86117 from the National Cancer Institute, and by NIH/NCCR UCSF-CTSI Grant number UL 1 RR024131.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walsh, J.M.E., Kim, S.E., Sawaya, G. et al. Colorectal Cancer Screening: What Do Women From Diverse Ethnic Groups Want?. J GEN INTERN MED 28, 239–246 (2013). https://doi.org/10.1007/s11606-012-2210-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-012-2210-6